Search Results - "Ippoliti, Andrew"

A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease by Tong, Maomeng, Li, Xiaoxiao, Wegener Parfrey, Laura, Roth, Bennett, Ippoliti, Andrew, Wei, Bo, Borneman, James, McGovern, Dermot P B, Frank, Daniel N, Li, Ellen, Horvath, Steve, Knight, Rob, Braun, Jonathan

“…Abnormalities of the intestinal microbiota are implicated in the pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC), two spectra of inflammatory…”
Get full text

Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease by MELMED, Gil Y, AGARWAL, Nik, VASILIAUSKAS, Eric A, FRENCK, Robert W, IPPOLITI, Andrew F, IBANEZ, Patricio, PAPADAKIS, Konstantinos A, SIMPSON, Peter, BAROLET-GARCIA, Cristina, WARD, Joel, TARGAN, Stephan R

“…The treatment of inflammatory bowel disease (IBD) often includes immunosuppressive medications, which may increase the risk of vaccine-preventable illnesses…”
Get full text

Patients with Inflammatory Bowel Disease are at Risk for Vaccine-Preventable Illnesses by MELMED, Gil Y, IPPOLITI, Andrew F, PAPADAKIS, Konstantinos A, TRAN, Tram T, BIRT, Jaime L, LEE, Susie K, FRENCK, Robert W, TARGAN, Stephan R, VASILIAUSKAS, Eric A

“…Patients with chronic, immune-mediated conditions such as inflammatory bowel disease (IBD) are often treated with long-term immunosuppressive therapies,…”
Get full text

Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome by Jacobs, Jonathan P, Goudarzi, Maryam, Lagishetty, Venu, Li, Dalin, Mak, Tytus, Tong, Maomeng, Ruegger, Paul, Haritunians, Talin, Landers, Carol, Fleshner, Philip, Vasiliauskas, Eric, Ippoliti, Andrew, Melmed, Gil, Shih, David, Targan, Stephan, Borneman, James, Fornace, Jr, Albert J, McGovern, Dermot P B, Braun, Jonathan

“…Crohn's disease (CD) patients demonstrate distinct intestinal microbial compositions and metabolic characteristics compared to unaffected controls. However,…”
Get full text

Genetic predictors of medically refractory ulcerative colitis by Haritunians, Talin, Taylor, Kent D., Targan, Stephan R., Dubinsky, Marla, Ippoliti, Andrew, Kwon, Soonil, Guo, Xiuqing, Melmed, Gil Y., Berel, Dror, Mengesha, Emebet, Psaty, Bruce M., Glazer, Nicole L., Vasiliauskas, Eric A., Rotter, Jerome I., Fleshner, Phillip R., McGovern, Dermot P.B.

“…Background: Acute severe ulcerative colitis (UC) remains a significant clinical challenge and the ability to predict, at an early stage, those individuals at…”
Get full text

Host–microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal–luminal interface by Presley, Laura L., Ye, Jingxiao, Li, Xiaoxiao, LeBlanc, James, Zhang, Zhanpan, Ruegger, Paul M., Allard, Jeff, McGovern, Dermot, Ippoliti, Andrew, Roth, Bennett, Cui, Xinping, Jeske, Daniel R., Elashoff, David, Goodglick, Lee, Braun, Jonathan, Borneman, James

“…Background: Host–microbe interactions at the intestinal mucosal–luminal interface (MLI) are critical factors in the biology of inflammatory bowel disease…”
Get full text

Both Preoperative Perinuclear Antineutrophil Cytoplasmic Antibody and Anti-CBir1 Expression in Ulcerative Colitis Patients Influence Pouchitis Development After Ileal Pouch–Anal Anastomosis by Fleshner, Phillip, Ippoliti, Andrew, Dubinsky, Marla, Vasiliauskas, Eric, Mei, Ling, Papadakis, Konstantinos A, Rotter, Jerome I, Landers, Carol, Targan, Stephan

“…Background & Aims: Acute pouchitis (AP) and chronic pouchitis (CP) are common after ileal pouch–anal anastomosis (IPAA) for ulcerative colitis. The aim of this…”
Get full text

A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface by Li, Xiaoxiao, LeBlanc, James, Truong, Allison, Vuthoori, Ravi, Chen, Sharon S, Lustgarten, Jonathan L, Roth, Bennett, Allard, Jeff, Ippoliti, Andrew, Presley, Laura L, Borneman, James, Bigbee, William L, Gopalakrishnan, Vanathi, Graeber, Thomas G, Elashoff, David, Braun, Jonathan, Goodglick, Lee

“…Aberrant interactions between the host and the intestinal bacteria are thought to contribute to the pathogenesis of many digestive diseases. However, studying…”
Get full text

Capsule endoscopy in patients with Crohn's disease: diagnostic yield and safety by Mehdizadeh, Shahab, MD, Chen, Gary C., MD, Barkodar, Linda, MD, Enayati, Pedram J., MD, Pirouz, Shahriar, MD, Yadegari, Michael, MD, Ippoliti, Andrew, MD, Vasiliauskas, Eric A., MD, Lo, Simon K., MD, Papadakis, Konstantinos Antonios, MD

“…Background Capsule endoscopy (CE) is increasingly used in patients with suspected or known Crohn's disease (CD). Objective To determine the diagnostic yield of…”
Get full text

Family History and Serology Predict Crohn’s Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis by Melmed, Gil Y., Fleshner, Phillip R., Bardakcioglu, Ovunc, Ippoliti, Andrew, Vasiliauskas, Eric A., Papadakis, Konstantinos A., Dubinsky, Marla, Landers, Carol, Rotter, Jerome I., Targan, Stephan R.

“…Purpose Approximately 5 to 10 percent of patients undergoing ileal pouch-anal anastomosis with a diagnosis of ulcerative colitis are subsequently diagnosed…”
Get full text

Hepatotoxicity of 6-Mercaptopurine (6-MP) and Azathioprine (AZA) in Adult IBD Patients by SHAYE, Omid A, YADEGARI, Michael, ABREU, Maria T, POORDAD, Fred, SIMON, Karen, MARTIN, Paul, PAPADAKIS, Konstantinos A, IPPOLITI, Andrew, VASILIAUSKAS, Eric, TRAN, Tram T

“…6-Mercaptopurine (6-MP) and azathioprine (AZA) are effective in the treatment of IBD; however, drug-induced hepatotoxicity has been reported in 10-15% of…”
Get full text

Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn’s Colitis by Taleban, Sasha, Van Oijen, Martijn G. H., Vasiliauskas, Eric A., Fleshner, Phillip R., Shen, Bo, Ippoliti, Andrew F., Targan, Stephan R., Melmed, Gil Y.

“…Background Much of the economic burden of Crohn’s disease (CD) is related to surgery. Twenty percent of patients with CD have isolated colonic disease. While…”
Get full text

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis by Cho, Judy H, Taylor, Kent D, Daly, Mark J, Silverberg, Mark S, Nicolae, Dan L, Goyette, Philippe, Steinhart, A Hillary, Rotter, Jerome I, Schumm, L Philip, Duerr, Richard H, Shugart, Yin Yao, Griffiths, Anne M, Huett, Alan, Ippoliti, Andrew F, Bernard, Edmond-Jean, Kuballa, Petric, Xavier, Ramnik J, Barmada, M Michael, Rioux, John D, Datta, Lisa Wu, Green, Todd, Regueiro, Miguel, Targan, Stephan R, Brant, Steven R, Mei, Ling

“…We present a genome-wide association study of ileal Crohn disease and two independent replication studies that identify several new regions of association to…”
Get full text

Sa1965 The Steady-State Pharmacokinetics of Adalimumab: Do We Need to Drink From the “Trough”? by Stewart, Michael J, Dubinsky, Marla, Morganstern, Bradley, Vasiliauskas, Eric, Targan, Stephan, Ippoliti, Andrew, Shih, David Q, Mould, Diane, McGovern, Dermot, Melmed, Gil Y

Get full text

High‐frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females by Saruta, Masayuki, Targan, Stephan R., Mei, Ling, Ippoliti, Andrew F., Taylor, Kent D., Rotter, Jerome I.

“…Background: TNF‐α and IL‐1 have been associated with mucosal inflammation in both Crohn's disease (CD) and ulcerative colitis (UC). Innate immune defects have…”
Get full text

Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus by Dulai, Gareth S., Jensen, Dennis M., Cortina, Galen, Fontana, Lana, Ippoliti, Andrew

“…Endoscopic ablation of Barrett's esophagus has been described in which various thermocoagulation modalities are used in combination with a high dose of a…”
Get full text

IL23R haplotypes provide a large population attributable risk for Crohn's disease by Taylor, Kent D., Targan, Stephan R., Mei, Ling, Ippoliti, Andrew F., McGovern, Dermot, Mengesha, Emebet, King, Lily, Rotter, Jerome I.

“…Background: The IL‐23 pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the inflammatory bowel diseases. Multiple studies…”
Get full text

New Clinical Method for Distinguishing D-IBS from Other Gastrointestinal Conditions Causing Diarrhea: The LA/IBS Diagnostic Strategy by Pimentel, Mark, Hwang, Laura, Melmed, Gil Y., Low, Kimberly, Vasiliauskas, Eric, Ippoliti, Andrew, Yang, Janet, Lezcano, Sheila, Conklin, Jeffrey L., Sahakian, Ara

“…Modern methods of diagnosing diarrhea-predominant irritable bowel syndrome (D-IBS) require a “diagnosis of exclusion” approach. In this study we aim to test…”
Get full text

Colorectal cancer screening and surveillance in Crohn's colitis by Basseri, Robert J., Basseri, Benjamin, Vassilaki, Maria E., Melmed, Gil Y., Ippoliti, Andrew, Vasiliauskas, Eric A., Fleshner, Philip R., Lechago, Juan, Hu, Bing, Berel, Dror, Targan, Stephan R., Papadakis, Konstantinos A.

“…To assess colonoscopic screening and surveillance for detecting neoplasia in patients with long-standing colonic Crohn's disease (CD). Colonoscopy and biopsy…”
Get full text

Predicting a Change in Diagnosis From Ulcerative Colitis to Crohn’s Disease: A Nested, Case-Control Study by Melmed, Gil Y, Elashoff, Robert, Chen, Gary C, Nastaskin, Igor, Papadakis, Konstantinos A, Vasiliauskas, Eric A, Liu, Weiqing, Landers, Carol, Ippoliti, Andrew F, Targan, Stephan R

“…Background & Aims: Some patients diagnosed with UC undergo a change in diagnosis to CD. Identification of predictors of a diagnostic change could potentially…”
Get full text